EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+59.14%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$605M
AUM Growth
+$605M
(+59%)
Cap. Flow
+$75.6M
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
55.57%
Holding
81
New
22
Increased
20
Reduced
20
Closed
14
Top Buys
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$31M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$27.2M |
| 3 |
Danaher
DHR
|
$22.3M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$15.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 96.24% |
| 2 | Communication Services | 1.96% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zymeworks
ZYME
$1.12B
| $1.44M | 0.2% | +40,000 | New | +$1.44M |
|
52
Carisma Therapeutics
CARM
$8.98M
| $1.44M | 0.2% | 2,000,000 +700,000 | +54% | +$504K |
|
53
Protara Therapeutics
TARA
$120M
| $1.36M | 0.19% | 46,310 +13,832 | +43% | +$406K |
|
54
Xoma
XOMA
$392M
| $1.27M | 0.17% | +64,056 | New | +$1.27M |
|
55
Solid Biosciences
SLDB
$427M
| $1.19M | 0.16% | +407,024 | New | +$1.19M |
|
56
KalVista Pharmaceuticals
KALV
$678M
| $1.09M | 0.15% | +89,806 | New | +$1.09M |
|
57
uniQure
QURE
$896M
| $1.03M | 0.14% | +22,928 | New | +$1.03M |
|
58
Dynavax Technologies
DVAX
$1.19B
| $867K | 0.12% | +97,800 | New | +$867K |
|
|
TLGT
59
DELISTED
Teligent, Inc
TLGT
| $859K | 0.12% | 354,998 -3,507,905 | -91% | -$8.49M |
|
|
BNR
60
Burning Rock Biotech
BNR
$93.6M
| $810K | 0.11% | +30,000 | New | +$810K |
|
|
RVLP
61
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $532K | 0.07% | +79,037 | New | +$532K |
|
|
EIGR
62
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $470K | 0.06% | 49,008 -20,700 | -30% | -$199K |
|
63
Immunovant
IMVT
$2.56B
| $299K | 0.04% | 12,266 -64,600 | -84% | -$1.57M |
|
64
Air Lease Corp
AL
$6.73B
| – | – | 0 | – | – |
|
65
Align Technology
ALGN
$10.3B
| – | – | 0 | – | – |
|
66
Aquestive Therapeutics
AQST
$456M
| – | – | -300,000 | Closed | -$657K |
|
67
eHealth
EHTH
$118M
| – | – | -3,153 | Closed | -$444K |
|
68
InflaRx
IFRX
$108M
| – | – | -195,488 | Closed | -$747K |
|
|
IGMS
69
DELISTED
IGM Biosciences
IGMS
| – | – | -9,770 | Closed | -$549K |
|
70
Iovance Biotherapeutics
IOVA
$807M
| – | – | -90,047 | Closed | -$2.7M |
|
71
MacroGenics
MGNX
$112M
| – | – | -91,998 | Closed | -$535K |
|
72
Envista
NVST
$3.52B
| – | – | -109,212 | Closed | -$1.63M |
|
73
Puma Biotechnology
PBYI
$254M
| – | – | -58,251 | Closed | -$492K |
|
74
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
75
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -71,591 | Closed | -$812K |
|